Detalhe da pesquisa
1.
Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.
Chem Rev
; 121(4): 2545-2647, 2021 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33543942
2.
Selective lowering of synapsins induced by oligomeric α-synuclein exacerbates memory deficits.
Proc Natl Acad Sci U S A
; 114(23): E4648-E4657, 2017 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28533388
3.
Discrete Pools of Oligomeric Amyloid-ß Track with Spatial Learning Deficits in a Mouse Model of Alzheimer Amyloidosis.
Am J Pathol
; 188(3): 739-756, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29248459
4.
Tau is required for progressive synaptic and memory deficits in a transgenic mouse model of α-synucleinopathy.
Acta Neuropathol
; 138(4): 551-574, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31168644
5.
Comment on "Activation of the Omega-3 Fatty Acid Receptor GPR120 Protects against Focal Cerebral Ischemic Injury by Preventing Inflammation and Apoptosis in Mice".
J Immunol
; 209(7): 1229-1233, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36167357
6.
Bidirectional modulation of Alzheimer phenotype by alpha-synuclein in mice and primary neurons.
Acta Neuropathol
; 136(4): 589-605, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29995210
7.
Soluble Conformers of Aß and Tau Alter Selective Proteins Governing Axonal Transport.
J Neurosci
; 36(37): 9647-58, 2016 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27629715
8.
Genetic modulation of soluble Aß rescues cognitive and synaptic impairment in a mouse model of Alzheimer's disease.
J Neurosci
; 34(23): 7871-85, 2014 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-24899710
9.
Brain amyloid-ß oligomers in ageing and Alzheimer's disease.
Brain
; 136(Pt 5): 1383-98, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23576130
10.
Soluble α-synuclein is a novel modulator of Alzheimer's disease pathophysiology.
J Neurosci
; 32(30): 10253-66, 2012 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-22836259
11.
The complex PrP(c)-Fyn couples human oligomeric Aß with pathological tau changes in Alzheimer's disease.
J Neurosci
; 32(47): 16857-71a, 2012 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-23175838
12.
Soluble Aß oligomer production and toxicity.
J Neurochem
; 120 Suppl 1: 125-139, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22121920
13.
A specific amyloid-beta protein assembly in the brain impairs memory.
Nature
; 440(7082): 352-7, 2006 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-16541076
14.
SNCA genetic lowering reveals differential cognitive function of alpha-synuclein dependent on sex.
Acta Neuropathol Commun
; 10(1): 180, 2022 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36517890
15.
Soluble endogenous oligomeric α-synuclein species in neurodegenerative diseases: Expression, spreading, and cross-talk.
J Parkinsons Dis
; 10(3): 791-818, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32508330
16.
Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity.
Brain
; 131(Pt 3): 651-64, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18292081
17.
Oligomers of the amyloid-beta protein disrupt working memory: confirmation with two behavioral procedures.
Behav Brain Res
; 193(2): 230-4, 2008 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-18585407
18.
The amyloid-ß oligomer Aß*56 induces specific alterations in neuronal signaling that lead to tau phosphorylation and aggregation.
Sci Signal
; 10(478)2017 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28487416
19.
NMDA receptor activation inhibits alpha-secretase and promotes neuronal amyloid-beta production.
J Neurosci
; 25(41): 9367-77, 2005 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-16221845
20.
Gain-of-function mutations in protein kinase Cα (PKCα) may promote synaptic defects in Alzheimer's disease.
Sci Signal
; 9(427): ra47, 2016 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27165780